Skip to main content

Articles

Page 16 of 16

  2. The known breast cancer susceptibility genes only account for 20% to 25% of the excess familial risk of the disease [1]. The present study assessed the contribution of BRCA1/2 mutations and CHEK2 variants to the ...

    Authors: Justo Lorenzo Bermejo, Alfonso García Pérez and Kari Hemminki
    Citation: Hereditary Cancer in Clinical Practice 2004 2:185
    Content type: Research Published on:

  3. To determine a cost-efficient strategy for HNPCC molecular diagnostic testing.

    Authors: Francesca Pigatto, Adrian Bateman, David Bunyan, Paul Strike, Esta Wilkins, Claire Curtis, Philippa Duncan, Denzil May, Karen Nugent and Diana Eccles
    Citation: Hereditary Cancer in Clinical Practice 2004 2:175
    Content type: Research Published on:

  4. Multiple Osteochondromas is an autosomal dominant disorder characterised by the presence of multiple osteochondromas and a variety of orthopaedic deformities. Two genes causative of Multiple Osteochondromas, Exos...

    Authors: Liesbeth Hameetman, Judith VMG Bovée, Antonie HM Taminiau, Herman M Kroon and Pancras CW Hogendoorn
    Citation: Hereditary Cancer in Clinical Practice 2004 2:161
    Content type: Review Published on:

  6. To asses the retinal pigment epithelium (RPE) function measured by EOG testing in patients with neurofibromatosis type 1 (NF-1). Our preliminary EOG results suggested dysfunction of the RPE in individuals with...

    Authors: Wojciech Lubiński, Stanisław Zajączek, Zbigniew Sych, Krzysztof Penkala, Olgierd Palacz and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2004 2:193
    Content type: Research Published on:

  10. To establish the contribution of TP53 germline mutations to familial breast/ovarian cancer in Germany we screened the complete coding region of the TP53 gene in a series of German breast/ovarian cancer families n...

    Authors: Xuan Liu, Hans-Peter Sinn, Hans Ulrich Ulmer, Rodney J Scott and Ute Hamann
    Citation: Hereditary Cancer in Clinical Practice 2004 2:139
    Content type: Research Published on:

  11. Several studies have demonstrated that familial breast cancers associated with BRCA1 or BRCA2 germline mutations differ in their morphological and immunohistochemical characteristics. Cancers associated with BRCA...

    Authors: Emiliano Honrado, Javier Benítez and José Palacios
    Citation: Hereditary Cancer in Clinical Practice 2004 2:131
    Content type: Review Published on:

  12. Prostate cancer is the most common cancer in men and the second highest cause of cancer-related mortality in the U.K. A genetic component in predisposition to prostate cancer has been recognized for decades. O...

    Authors: Sashi Kommu, Stephen Edwards and Rosalind Eeles
    Citation: Hereditary Cancer in Clinical Practice 2004 2:111
    Content type: Review Published on:

  14. Approximately 3-15% of all malignant melanomas (MM) are familial cases. MM is a highly heterogeneous tumour type from a genetic perspective. Pedigrees with disease confined to a single generation of siblings o...

    Authors: Tadeusz Dębniak
    Citation: Hereditary Cancer in Clinical Practice 2004 2:123
    Content type: Review Published on:

  16. We report three Dutch families with familial clustering of (pre)neoplastic cervical disease, review the literature on familial risks of cervical intraepithelial neoplasia (CIN) and cervical cancer, and discuss...

    Authors: Margreet Zoodsma, Rolf H Sijmons, Elisabeth GE de Vries and Ate GJ van der Zee
    Citation: Hereditary Cancer in Clinical Practice 2004 2:99
    Content type: Research Published on:

  17. Approximately 10% of gastric cancer cases show familial clustering but only 1-3% of gastric carcinomas arise as a result of inherited gastric cancer predisposition syndromes. Direct proof that Hereditary Gastr...

    Authors: Carla Oliveira, Gianpaolo Suriano, Paulo Ferreira, Paulo Canedo, Pardeep Kaurah, Rita Mateus, Ana Ferreira, António C Ferreira, Maria José Oliveira, Céu Figueiredo, Fátima Carneiro, Gisela Keller, David Huntsman, José Carlos Machado and Raquel Seruca
    Citation: Hereditary Cancer in Clinical Practice 2004 2:51
    Content type: Review Published on:

  18. Familial adenomatous polyposis (FAP) is characterized by the presence of hundreds to thousands of adenomas that carpet the entire colon and rectum. Nonsense and frameshift mutations in the adenomatous polyposi...

    Authors: Rodney J Scott, Renee Crooks, Lindy Rose, John Attia, Ammarin Thakkinstian, Lesley Thomas, Allan D Spigelman and Cliff J Meldrum
    Citation: Hereditary Cancer in Clinical Practice 2004 2:81
    Content type: Research Published on:

  19. To determine which individuals with colorectal cancer (CRC) were interested in knowing the results of their tumour microsatellite instability (MSI) and immunohistochemistry (IHC) testing. We were also interest...

    Authors: Noralane M Lindor, Jeff Sloan, Richard Goldberg, Deborah Bowen, Sandra Nigon, Amber Roche, Gloria Petersen, Stephen N Thibodeau, Laurence Burgart, Olga Leontovich and Bruce W Morlan
    Citation: Hereditary Cancer in Clinical Practice 2004 2:69
    Content type: Research Published on:

  20. Gastric cancer is the second most frequently diagnosed malignancy worldwide and therefore represents a significant healthcare burden. Environmental and genetic factors are involved in the development of gastri...

    Authors: Beata Gawdis-Wojnarska, Marek Brzosko, Jacek Fliciński, Krzysztof Marlicz, Teresa Starzyńska, Rodney J Scott and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2004 2:65
    Content type: Research Published on:

  21. Central nervous system hemangioblastomas (cHAB) are rare tumours which most commonly arise in the cerebellum. Most tumours are sporadic, but as many as one third of cHABs occur in the course of the hereditary ...

    Authors: Cezary Cybulski, Joanna Matyjasik, Marianna Soroka, Janusz Szymaś, Bohdan Górski, Tadeusz Dębniak, Anna Jakubowska, Andrzej Bernaczyk, Lech Zimnoch, Grażyna Bierzyńska-Macyszyn, Tomasz Trojanowski, Teresa Wierzba-Bobrowicz, Edmund Prudlak, Alicja Markowska-Wojciechowska, Przemysław Nowacki, Andrzej Roszkiewicz…
    Citation: Hereditary Cancer in Clinical Practice 2004 2:93
    Content type: Short report Published on:

  22. There is much debate in the literature about familial predispositions to breast and bowel cancers yet little evidence is forthcoming to suggest that there are susceptibility genes that can account for such kin...

    Authors: Rodney J Scott and Katie A Ashton
    Citation: Hereditary Cancer in Clinical Practice 2004 2:25
    Content type: Review Published on:

  23. When BRCA1/2 genetic susceptibility testing was introduced in the clinic in the mid-nineties, the "Huntington protocol" was used in the counselling of individuals applying for genetic testing. This protocol inclu...

    Authors: Iris van Oostrom and Aad Tibben
    Citation: Hereditary Cancer in Clinical Practice 2004 2:19
    Content type: Review Published on:

  26. This paper highlights the need for carriers to be followed up by health professionals who understand the complexities of the BRCA syndrome. A BRCA carrier clinic has been established in London and regular follow ...

    Authors: Audrey Ardern-Jones and Rosalind Eeles
    Citation: Hereditary Cancer in Clinical Practice 2004 2:77
    Content type: Case report Published on:

  28. The aim of the study is to evaluate the incidence and phenotype - genotype characteristics of hereditary colorectal cancer syndromes in Latvia in order to develop the basis of clinical management for patients ...

    Authors: Arvids Irmejs, Andris Gardovskis, Viktors Borosenko, Marianna Bitina, Diana Aigare, Grzegorz Kurzawski, Janina Suchy, Bohdan Górski and Janis Gardovskis
    Citation: Hereditary Cancer in Clinical Practice 2003 1:49
    Content type: Research Published on:

  29. Denaturing high performance liquid chromatography is a relatively new method by which heteroduplex structures formed during the PCR amplification of heterozygote samples can be rapidly identified. The use of t...

    Authors: Cliff J. Meldrum, Mary McPhillips, Renee Crooks, Lesley Thomas, Ted Edkins, Rohanna Creegan, Ewan Miller, Michael Agrez and Rodney J. Scott
    Citation: Hereditary Cancer in Clinical Practice 2003 1:39
    Content type: Research Published on:

  30. The criteria for the diagnosis of HNPCC established by the ICG-HNPCC are very restrictive as they do not allow for the diagnosis of a large number of "suspected HNPCC" cases - these are families which do no fu...

    Authors: Józef Kładny, Gabriela Möslein, Torben Myrhøj, Grzegorz Kurzawski, Anna Jakubowska, Tadeusz Dębniak, Wojciech Petriczko, Michał Kozłowski, Tariq Al-Amawi, Marek Brzosko, Jacek Fliciński, Arkadiusz Jawień, Zbigniew Banaszkiewicz, Piotr Rychter and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2003 1:34
    Content type: Research Published on:

  31. In addition to a relatively small number of well known hereditary cancer syndromes, hundreds of presumed or proven hereditary disorders have been observed to manifest cancer as a characteristic feature or as a...

    Authors: Rolf H. Sijmons and Gerard T.N. Burger
    Citation: Hereditary Cancer in Clinical Practice 2003 1:31
    Content type: Commentary Published on:

  33. HNPCC (Lynch syndrome) is the most common form of hereditary colorectal cancer (CRC), wherein it accounts for between 2-7 percent of the total CRC burden. When considering the large number of extracolonic canc...

    Authors: Henry T. Lynch, Jane F. Lynch, Trudy G. Shaw and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2003 1:7
    Content type: Review Published on:
Submit manuscript

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.0
    5-year Journal Impact Factor: 1.9
    Source Normalized Impact per Paper (SNIP): 0.569
    SCImago Journal Rank (SJR): 0.729

    Speed 2023
    Submission to first editorial decision (median days): 5
    Submission to acceptance (median days): 131

    Usage 2023
    Downloads: 394,813
    Altmetric mentions: 196

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287